Evidence map›Paper›PMID 9878045›Full record

ArticleThe EMBO journal1999

Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.

A C Papageorgiou, C M Collins, D M Gutman, J B Kline, S M O'Brien, H S Tranter, K R Acharya

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Crystal structure of a dimeric form of streptococcal pyrogenic exotoxin A (SpeA1).Protein science : a publication of the Protein Society · 2004
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster.Protein science : a publication of the Protein Society · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

A C PapageorgiouDepartment of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK.
C M Collins
D M Gutman
J B Kline
S M O'Brien
H S Tranter
K R Acharya
University of Bath · GB

Funding

MOLECULAR INTERACTIONS BETWEEN SPEA AND THE TCRR01AI042353 · NIAID · UNIVERSITY OF WASHINGTON · PI COLLINS, CARLEEN M. · 1998 to 2002
$738k
NIAID NIH HHS AI 42353
6 · The paper itself

Abstract

Streptococcal pyrogenic exotoxin A (SpeA) is a superantigen produced by Streptococcus pyogenes and is associated with severe infections characterized by rash, hypotension, multiorgan failure and a high mortality rate. In this study, an allelic form of this toxin, SpeA1, was crystallized with four molecules in the crystallographic asymmetric unit and its crystal structure was determined at 2.6 A resolution. The crystallographic R-factor was 19.4% (33 497 reflections) for 7031 protein atoms and 88 water molecules. The overall structure of SpeA1 is considerably similar to that of other prototype microbial superantigens, either of staphylococcal or streptococcal origin, but has greatest similarity to staphylococcal enterotoxin C (SEC). Based on structural and mutagenesis data, we have mapped several important residues on the toxin molecule, which are involved in the recognition of major histocompatibility complex (MHC) class II molecules and T-cell receptors. Also, the toxin appears to possess a potential zinc-binding site which may have implications in binding to particular MHC class II molecules. Finally, we propose models for SpeA1-MHC class II and SpeA1-T-cell receptor association and the relevance of this phenomenon to the superantigenic action of this toxin is considered.

Indexed as

Bacterial ProteinsMembrane ProteinsAmino Acid SequenceBinding SitesCrystallography, X-RayExotoxinsHistocompatibility Antigens Class IIHumansModels, MolecularMolecular Sequence DataProtein ConformationPyrogensReceptors, Antigen, T-CellRecombinant Fusion ProteinsStreptococcus pyogenesSuperantigensBacterial Proteinserythrogenic toxinExotoxinsHistocompatibility Antigens Class IIMembrane ProteinsPyrogensReceptors, Antigen, T-CellRecombinant Fusion ProteinsSpeA protein, Streptococcus pyogenesSuperantigens

Identifiers

PMID9878045
PMCPMC1171097
OpenAlexW2083175456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.